Related Experiment Video
Updated: Mar 29, 2026
08:52
Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes
Published on: July 26, 2019
8.7K
Correction: HIV microarray for the mapping and characterization of HIV-specific antibody responses
Daniela Gallerano1, Eva Wollmann1, Christian Lupinek1
1Division of Immunopathology, Department of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Währinger Gürtel 18-20, 3Q, 1090 Vienna, Austria. rudolf.valenta@meduniwien.ac.at.
Lab on a Chip
|December 10, 2015
Summary
This correction clarifies details regarding the HIV microarray used for mapping and characterizing HIV-specific antibody responses. It ensures accurate representation of the methodology and findings presented in the original study.
Area of Science:
- Immunology
- Biotechnology
- Microfluidics
Context:
- Accurate characterization of antibody responses is crucial for vaccine development and understanding HIV pathogenesis.
- Microarray technology offers a high-throughput platform for analyzing complex immune profiles.
Purpose:
- To correct and clarify specific details within the original publication concerning the HIV microarray.
- To ensure the integrity and reproducibility of research on HIV-specific antibody responses.
Summary:
- The correction addresses specific technical or data-related aspects of the HIV microarray methodology.
- It refines the description of how HIV-specific antibody responses were mapped and characterized using the microarray platform.
Impact:
- Ensures the scientific record accurately reflects the capabilities and application of the HIV microarray.
- Facilitates correct interpretation of HIV-specific antibody data by researchers in the field.
